Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast pharmacogenetic response study in adults with asthma
2008-001008-21Phase 4Completed
- Sponsor
- Policlinico Gemelli
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of montelukast in asthma, sponsored by Policlinico Gemelli. Primary endpoints: Exhaled nitric oxide response, Pre-bronchodilator FEF25%-75% response and 1 more. Started Mar 2008; status: completed.
02
Drugs
montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on 2008-001008-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001008-21.